The Phantom Mark: Enigmatic roles of phospho‐Threonine 4 modification of the C‐terminal domain of RNA polymerase II
WIREs RNA · 2023
DOI: 10.1002/wrna.1771 ↗Kurz gefasst
Fachartikel in der Zeitschrift WIREs RNA, 2023. Verfasst von Ryan P Kempen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Biology & Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA. Hauptthemen laut MEDLINE: RNA Polymerase II, Transcription, Genetic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIH HHS, American Lebanese Syrian Associated Charities.
Abstract (Originalsprache)
The largest subunit of RNA polymerase II (Pol II) has an unusual carboxyl‐terminal domain (CTD). This domain is composed of a tandemly repeating heptapeptide, Y 1 S 2 P 3 T 4 S 5 P 6 S 7 , that has multiple roles in regulating Pol II function and processing newly synthesized RNA. Transient phosphorylation of Ser2 and Ser5 of the Y S 2 PT S 5 PS repeat have well‐defined roles in recruiting different protein complexes and coordinating sequential steps in gene transcription. As such, these phospho‐marks encipher a molecular recognition code, colloquially termed the CTD code. In contrast, the contribution of phospho‐Threonine 4 (pThr4/pT4) to the CTD code remains opaque and contentious. Fuelling the debate on the relevance of this mark to gene expression are the findings that replacing Thr4 with a valine or alanine has varied impact on cellular function in different species and independent proteomic analyses disagree on the relative abundance of pThr4 marks. Yet, substitution with negatively charged residues is lethal and even benign mutations selectively disrupt synthesis and 3′ processing of distinct sets of coding and non‐coding transcripts. Suggestive of non‐canonical roles, pThr4 marked Pol II regulates distinct gene classes in a species‐ and signal‐responsive manner. Hinting at undiscovered roles of this elusive mark, multiple signal‐responsive kinases phosphorylate Thr4 at target genes. Here, we focus on this under‐explored residue and postulate that the pThr4 mark is superimposed on the canonical CTD code to selectively regulate expression of targeted genes without perturbing genome‐wide transcriptional processes. This article is categorized under: RNA Processing > 3′ End Processing RNA Processing > Processing of Small RNAs RNA Processing > Splicing Regulation/Alternative Splicing
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Biology & Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
ORCID-Profile: Ryan P Kempen, Preeti Dabas, Aseem Z Ansari
Förderung
- NIGMS NIH HHS
- NIH HHS
- American Lebanese Syrian Associated Charities
- National Institutes of Health
- National Science Foundation
Zitieren
APA
Kempen, R. P., Dabas, P., & Ansari, A. Z. (2023). The Phantom Mark: Enigmatic roles of phospho‐Threonine 4 modification of the C‐terminal domain of RNA polymerase II. WIREs RNA. https://doi.org/10.1002/wrna.1771
Vancouver
Kempen RP, Dabas P, Ansari AZ. The Phantom Mark: Enigmatic roles of phospho‐Threonine 4 modification of the C‐terminal domain of RNA polymerase II. WIREs RNA. 2023. doi:10.1002/wrna.1771
BibTeX
@article{Kempen2023,
author = {Kempen, Ryan P and Dabas, Preeti and Ansari, Aseem Z},
title = {The Phantom Mark: Enigmatic roles of phospho‐Threonine 4 modification of the C‐terminal domain of RNA polymerase II},
journal = {WIREs RNA},
year = {2023},
doi = {10.1002/wrna.1771}
}
EUVIMED